Class Review Schedule

The next D&T Committee meeting will be held September 13, 2017

HFS will be reviewing the following classes for the September meeting:


Diabetes DPP-4 Inhibitors


Diabetes GLP-1 Receptor Agonists


Diabetes SGLT2 Inhibitors


Diabetes Long Acting Insulin


Stimulants/ADHD Agents


All clinical and financial submissions for this meeting must be sent to the Department no later than 3pm CST on August 23, 2017.  Any changes to drug status will become effective on or after October 1, 2017.









 Need Assistance?